Background: We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil.
Methods: Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil.
Results: The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively.
Conclusions: The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/0037-8682-0238-2023 | DOI Listing |
Publication Analysis
Top Keywords
genotype® mtbdrplus
16
são paulo
8
costs genotype®
8
cost genotype®
8
genotype®
6
cost
4
cost analysis
4
analysis genotype®
4
mtbdrplus
4
mtbdrplus genotype®
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!